The Johns Hopkins Heartburn Center Registry
Launched by JOHNS HOPKINS UNIVERSITY · Feb 22, 2019
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This registry is a prospective, multicenter registry of patients undergoing diagnostic evaluation and/or treatment of gastroesophageal reflux disease and associated diseases and complications.
Patients who are eligible will have disease and therapy-specific data collected throughout treatment and long-term (5-year) follow-up.
Electronic data capture via REDCap will be utilized for all sites.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Referred GERD patients willing to participate in long term follow-up (5 years)
- Exclusion Criteria:
- • Potential participants will be excluded if unwilling or unable to complete surveillance questionnaires through this registry
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Baltimore, Maryland, United States
Rochester, Minnesota, United States
New York, New York, United States
Danville, Pennsylvania, United States
Houston, Texas, United States
Orange, California, United States
Reno, Nevada, United States
Bay City, Texas, United States
Appleton, Wisconsin, United States
Patients applied
Trial Officials
Marcia Canto, MD
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials